MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c): Research, Mechanism & Current Evidence

What is MOTS-c?

MOTS-c is a short peptide of sixteen amino acids that is unusual in where it comes from: it is encoded by mitochondrial DNA rather than by the DNA in the cell nucleus. Mitochondria are the structures that generate most of a cell's energy, and they carry their own small genome.

It was identified in 2015 and belongs to a small group known as mitochondrial-derived peptides, alongside humanin.

What is MOTS-c researched for?

Insulin sensitivity and glucose handling, particularly in the context of diet-induced obesity in mice.

Exercise physiology — MOTS-c levels rise with physical activity, which has driven interest in whether it acts as part of the body's response to exercise.

Ageing biology, including whether levels decline over time and whether a genetic variant affects longevity in some populations.

• Improves insulin sensitivity by ~30% in animal studies through AMPK activation.
• Restores metabolic function via insulin receptor sensitization.
• Promotes fatty acid oxidation despite identical caloric intake.
• Reverses age-dependent physical decline in animal models.
• Enhances mitochondrial function via PGC-1α activation.
• 6.4% median lifespan extension observed in mice studies.
• 12-15% improvement in running performance from single dose in studies.
• Exercise induced 11.9-fold increase in skeletal muscle MOTS-c.
• Supports muscle recovery and adaptation to exercise.

How does MOTS-c work?

MOTS-c appears to act as a stress signal from the mitochondria to the rest of the cell. Under metabolic stress it moves into the cell nucleus and interacts with transcription factors that switch stress-response genes on and off.

It has also been linked to the folate–AICAR–AMPK pathway. AMPK is the cell's low-energy sensor: when energy runs short, AMPK activation shifts the cell toward burning fuel rather than storing it.

Reported targets: insulin receptor

What does the research show?

Mouse studies report improved insulin sensitivity and resistance to diet-induced obesity. Human data is observational — measuring circulating levels in relation to exercise, age and metabolic status — rather than interventional.

No controlled trial of administered MOTS-c in humans has been published.

Limitations of the current evidence

Observing that a peptide rises with exercise does not establish that administering it reproduces the benefits of exercise.

Lifespan and healthspan claims rest on mouse data and population genetics, not on human intervention studies.

References

1. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance

   Lee, C., et al. · Cell Metabolism · 2015

   Landmark discovery paper identifying MOTS-c as a 16-amino-acid peptide encoded by mitochondrial DNA. Prevented age-dependent and high-fat-diet-induced insulin resistance and obesity in mice via AMPK activation in skeletal muscle.

   Animal study

2. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress

   Kim KH, Son JM, Benayoun BA, et al. · Cell metabolism · 2018

   MOTS-c rapidly translocates to the nucleus within 30 minutes under metabolic stress in an AMPK-dependent manner, where it interacts with stress-responsive transcription factors including NRF2 and ATF7 to regulate nuclear gene expression.

   PMID 29983246

3. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

   Reynolds JC, Lai RW, Woodhead JST, et al. · Nature communications · 2021

   Exercise induced an 11.9-fold increase in skeletal muscle MOTS-c. MOTS-c enhanced physical performance across age groups and improved muscle homeostasis in aging mice.

   Animal study · PMID 33473109

4. MOTS-c increases in skeletal muscle following long-term physical activity and improves acute exercise performance after a single dose

   Hyatt JK · Physiological reports · 2022

   4-8 weeks of voluntary running increased MOTS-c protein expression ~1.5-5-fold in rodent skeletal muscles, sustained for 4-6 weeks of detraining. Single dose improved acute exercise performance.

   Animal study · PMID 35808870

5. The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus

   Yin Y, Pan Y, He J, et al. · Pharmacological research · 2022

   MOTS-c significantly alleviated hyperglycemia, improved insulin sensitivity and glucose tolerance, and reduced birth weight and offspring death in a gestational diabetes mouse model.

   Animal study · PMID 34798268

6. This information is for educational and research purposes only. Consult a healthcare professional before use.

7. A comprehensive research database for peptides, therapies, and protocols. Information provided for educational purposes only.

8. © 2026 Peptide Database. For educational and research purposes only.

9. A mitochondrially encoded hormone ameliorates obesity and insulin resistance

   Zarse K, Ristow M · Cell metabolism · 2015

   PMID 25738453

Common questions